You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

~ Buy the PIQRAY (alpelisib) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR PIQRAY

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Piqray

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02379247 ↗	BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer	Active, not recruiting	Novartis Pharmaceuticals	Phase 1/Phase 2	2015-02-01	Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer.
NCT02379247 ↗	BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer	Active, not recruiting	Priyanka Sharma	Phase 1/Phase 2	2015-02-01	Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer.
NCT02379247 ↗	BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer	Active, not recruiting	University of Kansas Medical Center	Phase 1/Phase 2	2015-02-01	Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer.
NCT03207529 ↗	Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer	Recruiting	Astellas Pharma Global Development, Inc.	Phase 1	2019-06-07	This phase I trial studies the side effects and best dose of alpelisib when given together with enzalutamide in treating patients with androgen receptor and PTEN positive breast cancer that has spread to other places in the body. Alpelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Androgen receptor can cause the growth of breast cancer cells. Hormone therapy using enzalutamide may fight breast cancer by lowering the amount of androgen the body makes. Giving alpelisib and enzalutamide may work better in treating patients with breast cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Piqray

Condition Name

Chart
Table

Condition Name for Piqray
Intervention	Trials
Breast Cancer	7
Metastatic Breast Cancer	4
Anatomic Stage III Breast Cancer AJCC v8	2
Prognostic Stage III Breast Cancer AJCC v8	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Piqray
Intervention	Trials
Breast Neoplasms	14
Carcinoma	3
Neoplasms	2
Dyslipidemias	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Piqray

Trials by Country

Map
Table

Trials by Country for Piqray
Location	Trials
United States	31
Argentina	1
Mexico	1
Brazil	1
Australia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Piqray
Location	Trials
New York	3
Texas	3
Missouri	3
Maryland	2
California	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Piqray

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Piqray
Clinical Trial Phase	Trials
Phase 3	2
Phase 2	6
Phase 1/Phase 2	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Piqray
Clinical Trial Phase	Trials
Not yet recruiting	10
Recruiting	5
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Piqray

Sponsor Name

Chart
Table

Sponsor Name for Piqray
Sponsor	Trials
Novartis	4
Celcuity, Inc.	2
Novartis Pharmaceuticals	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Piqray
Sponsor	Trials
Industry	15
Other	15
NIH	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.